Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.010
+0.010 (0.25%)
Mar 31, 2025, 4:00 PM EDT - Market closed

Cytek Biosciences Revenue

In the year 2024, Cytek Biosciences had annual revenue of $200.45M with 3.85% growth. Cytek Biosciences had revenue of $57.48M in the quarter ending December 31, 2024, a decrease of -1.30%.

Revenue (ttm)
$200.45M
Revenue Growth
+3.85%
P/S Ratio
2.61
Revenue / Employee
$309,341
Employees
648
Market Cap
513.67M

Revenue Chart

Created with Highcharts 11.4.8Cytek Biosciences Revenue - Annual92.84M92.84M128.0M128.0M164.0M164.0M193.0M193.0M200.5M200.5M20202021202220232024-50M100M150M200M

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024200.45M7.44M3.85%
Dec 31, 2023193.02M28.98M17.67%
Dec 31, 2022164.04M36.09M28.20%
Dec 31, 2021127.95M35.11M37.82%
Dec 31, 202092.84M34.96M60.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro
Dec 31, 2009 Pro Pro Pro
Dec 31, 2007 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings